Skip to main content

Table 4 The clinical outcome of different total Gn dosage groups with AMH stratification

From: Effects of total gonadotropin dose on embryo quality and clinical outcomes with AMH stratification in IVF cycles: a retrospective analysis of 12,588 patients

AMH levels

Total Gn dosage (IU)

P value

 < 1875 (A)

1875–3750 (B)

 ≥ 3750 (C)

PAB

PAC

PBC

The implantation rate (%)

 Age < 35 Y

  AMH ≤ 1 ng/ml

0

41.25 (217/526)

38.67 (198/512)

–

–

0.410

  1 < AMH ≤ 3 ng/ml

53.74 (503/936)

47.66 (1629/3418)

37.55 (190/506)

0.001

 < 0.001

 < 0.001

  3 < AMH ≤ 5 ng/ml

55.87 (856/1532)

50.94 (708/1390)

42.59 (23/54)

0.008

0.069

0.267

  AMH > 5 ng/ml

58.43 (582/996)

51.65 (219/424)

0

0.019

–

–

 Age 35–42 Y

  AMH ≤ 1 ng/ml

0

27.86 (73/262)

23.01 (127/552)

–

–

0.139

  1 < AMH ≤ 3 ng/ml

38.68 (41/106)

30.07 (329/1094)

24.81 (133/536)

0.078

0.004

0.030

  3 < AMH ≤ 5 ng/ml

34.66 (61/176)

30.75 (115/374)

21.05 (8/38)

0.379

0.127

0.266

  AMH > 5 ng/ml

47.22 (34/72)

36.11 (26/72)

0

0.237

–

–

The clinical pregnancy rate (%)

 Age < 35 Y

  AMH ≤ 1 ng/ml

0

61.98 (163/263)

57.42 (147/256)

–

–

0.325

  1 < AMH ≤ 3 ng/ml

76.50 (358/468)

69.87 (1194/1709)

60.87 (154/253)

0.006

 < 0.001

0.005

  3 < AMH ≤ 5 ng/ml

77.15 (591/766)

70.94 (493/695)

62.96 (17/27)

0.007

0.104

0.392

  AMH > 5 ng/ml

79.12 (394/498)

72.64 (154/212)

0

0.064

–

–

 Age 35–42 Y

  AMH ≤ 1 ng/ml

0

45.04 (59/131)

38.77 (107/276)

–

–

0.237

  1 < AMH ≤ 3 ng/ml

58.49 (31/53)

47.90 (262/547)

41.42 (111/268)

0.152

0.024

0.086

  3 < AMH ≤ 5 ng/ml

59.09 (52/88)

49.73 (93/187)

36.84 (7/19)

0.156

0.126

0.340

  AMH > 5 ng/ml

66.67 (24/36)

63.89 (23/36)

0

1.000

–

–

The live birth rate (%)

 Age < 35 Y

  AMH ≤ 1 ng/ml

0

47.53 (125/263)

44.14 (113/256)

–

–

0.481

  1 < AMH ≤ 3 ng/ml

58.12 (272/468)

56.35 (963/1709)

50.59 (128/253)

0.494

0.059

0.090

  3 < AMH ≤ 5 ng/ml

63.32 (485/766)

57.55 (400/695)

48.15 (13/27)

0.028

0.155

0.428

  AMH > 5 ng/ml

64.86 (323/498)

60.85 (129/212)

0

0.348

–

–

 Age 35–42 Y

  AMH ≤ 1 ng/ml

0

29.77 (39/131)

26.81 (74/276)

–

–

0.555

  1 < AMH ≤ 3 ng/ml

45.28 (24/53)

30.90 (169/547)

27.99 (75/268)

0.044

0.015

0.416

  3 < AMH ≤ 5 ng/ml

40.91 (36/88)

32.62 (61/187)

21.05 (4/19)

0.223

0.123

0.438

  AMH > 5 ng/ml

52.78 (19/36)

38.89 (14/36)

0

0.344

–

–

  1. The IVF-ET cycles of 2 embryos at the cleavage stage with endometrial thickness ≥ 7 mm on ET day were included. PAB: < 1875 IU group vs. 1875–3750 IU group. PAC: < 1875 IU group vs. ≥ 3750 IU group. PBC: 1875–3750 IU group vs. ≥ 3750 IU group. AMH anti-Müllerian hormone, Gn gonadotropin. P < 0.05 was considered statistically significant. -, not applicable